Device type · NOY
Agents, Embolic, For Treatment Of Benign Prostatic Hyperplasia
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
NOY
Gastroenterology & Urology
Device class
Class II
FDA decisions since 2015
4
510(k), De Novo and PMA
Adverse event reports
0
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Agents, Embolic, For Treatment Of Benign Prostatic Hyperplasia
- Product code
- NOY
- Device class
- Class II
- Review panel
- Gastroenterology & Urology
- Regulation
- 21 CFR 876.5550
- Specialty
- GI, Urology & Nephrology, Urology
- FDA record
- Classification database entry for NOY
Latest FDA decisions
Biocompatibles UK Ltd (Part of Boston Scientific Corporation
K203276 · Decided Apr 20, 2021 · 165 days after receipt
Device type: Agents, Embolic, For Treatment Of Benign Prostatic Hyperplasia (NOY) · GI, Urology & Nephrology
- HydroPearl Microspheres510(k)
K192684 · Decided Jan 22, 2020 · 118 days after receipt
Device type: Agents, Embolic, For Treatment Of Benign Prostatic Hyperplasia (NOY) · GI, Urology & Nephrology
K180102 · Decided Apr 19, 2018 · 93 days after receipt
Device type: Agents, Embolic, For Treatment Of Benign Prostatic Hyperplasia (NOY) · GI, Urology & Nephrology
- Embosphere MicrospheresNew device typeDe Novo
DEN160040 · Decided Jun 21, 2017 · 320 days after receipt
Device type: Agents, Embolic, For Treatment Of Benign Prostatic Hyperplasia (NOY) · GI, Urology & Nephrology
Reports received
0
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
No reports to chart for this view.
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
No manufacturers to rank.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
No device problems coded.
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
No patient problems coded.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0868-2024 · Started Dec 21, 2023 · Posted by FDA Jan 31, 2024
Reason given: Due to, during the manufacturing process, the prescribed manufacturing and quality processes were not followed and the product was inadvertently distributed.
Cause as FDA categorized it: Device Design
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.